A predictive model for survival in metastatic cancer patients attending an outpatient palliative radiotherapy clinic

被引:90
作者
Chow, E
Fung, KW
Panzarella, T
Bezjak, A
Danjoux, C
Tannock, I
机构
[1] Univ Toronto, Dept Radiat Oncol, Toronto Sunnybrook Reg Canc Ctr, Toronto, ON M4N 3M5, Canada
[2] Univ Toronto, Princess Margaret Hosp, Univ Hlth Network, Toronto, ON M4N 3M5, Canada
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2002年 / 53卷 / 05期
关键词
survival; prediction; palliative radiotherapy;
D O I
10.1016/S0360-3016(02)02832-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To develop a predictive model for survival from the time of presentation in an outpatient palliative radiotherapy clinic. Methods and Materials: Sixteen factors were analyzed prospectively in 395 patients seen in a dedicated palliative radiotherapy clinic in a large tertiary cancer center using Cox's proportional hazards regression model, Results: Six prognostic factors had a statistically significant impact on survival, as follows: primary cancer site, site of metastases, Karnofsky performance score (KPS), and fatigue, appetite, and shortness of breath scores from the modified Edmonton Symptom Assessment Scale. Risk group stratification was performed (1) by assigning weights to the prognostic factors based on their levels of significance, and (2) by the number of risk factors present. The weighting method provided a Survival Prediction Score (SPS), ranging from 0 to 32. The survival probability at 3, 6, and 12 months was 83%, 70%, and 51%, respectively, for patients with SPS less than or equal to13 (n = 133); 67%, 41%, and 20% for patients with SPS 14-19 (In = 129); and 36%, 18%, and 4% for patients with SPS greater than or equal to20 (n = 133) (p < 0.0001). Corresponding survival probabilities based on number of risk factors were as follows: 85%, 72%, and 52% (less than or equal to3 risk factors)(n = 98); 68%, 47%, and 24% (4 risk factors)(n = 117); and 46%, 24%, and 11% (greater than or equal to5 factors)(n = 180)(p < 0.0001). Conclusion: Clinical prognostic factors can be used to predict prognosis among patients attending a palliative radiotherapy clinic. If validated in an independent series of patients, the model can be used to guide clinical decisions, plan supportive services, and allocate resource use. (C) 2002 Elsevier Science Inc.
引用
收藏
页码:1291 / 1302
页数:12
相关论文
共 69 条
  • [51] PROSPECTIVE RANDOMIZED TRIAL OF SINGLE AND MULTIFRACTION RADIOTHERAPY SCHEDULES IN THE TREATMENT OF PAINFUL BONY METASTASES
    PRICE, P
    HOSKIN, PJ
    EASTON, D
    AUSTIN, D
    PALMER, SG
    YARNOLD, JR
    [J]. RADIOTHERAPY AND ONCOLOGY, 1986, 6 (04) : 247 - 255
  • [52] Bone metastasis: Review and critical analysis of random allocation trials of local field treatment
    Ratanatharathorn, V
    Powers, WE
    Moss, WT
    Perez, CA
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 44 (01): : 1 - 18
  • [53] CLINICAL SYMPTOMS AND LENGTH OF SURVIVAL IN PATIENTS WITH TERMINAL CANCER
    REUBEN, DB
    MOR, V
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (07) : 1586 - 1591
  • [54] Rosenthal Mark A., 1993, Palliative Medicine, V7, P199, DOI 10.1177/026921639300700306
  • [55] *SAS I INC, SAS STAT US GUID VER
  • [56] SOCIAL TIES AND MORTALITY IN EVANS COUNTY, GEORGIA
    SCHOENBACH, VJ
    KAPLAN, BH
    FREDMAN, L
    KLEINBAUM, DG
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1986, 123 (04) : 577 - 591
  • [57] Schonwetter R S, 1990, Hosp J, V6, P65
  • [58] Spiegel D, 1997, SEMIN ONCOL, V24, pS36
  • [59] SPIEGEL D, 1995, SUPPORT CARE CANCER, V3, P252
  • [60] The art and science of prognosis in patients with advanced cancer
    Steensma, DP
    Loprinzi, CL
    [J]. EUROPEAN JOURNAL OF CANCER, 2000, 36 (16) : 2025 - 2027